Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06276010
NA

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Sponsor: Xiaotong Hou

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effectiveness and safety of nafamostat mesilate compared with unfractionated heparin for anticoagulation in patients with ECMO after cardiac surgery.

Official title: Use of Nafamostat Mesilate for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation After Cardiac Surgery: Efficacy and Safety

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-07-01

Completion Date

2026-12-31

Last Updated

2025-09-25

Healthy Volunteers

No

Interventions

DRUG

nafamostat mesilate

Use nafamostat mesilate as an anticoagulant

DRUG

unfractionated heparin group

Use unfractionated heparin as an anticoagulant

Locations (1)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China